APPLICATION
ANDA091471
TYPE
ANDA
ORIGINAL APPROVAL
2016-02-17
LATEST ACTION
2021-10-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
EFAVIRENZDiscontinued
EFAVIRENZ 600MG · TABLET · ORAL
Approval history
2021-10-07Labeling · Supplement 4 · standardAP
2021-10-07Labeling · Supplement 2 · standardAP
2021-10-07Labeling · Supplement 5 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.